A microfluidics platform for combinatorial drug screening on cancer biopsies
Cancer patients exhibit specific sensitivities toward drug combinations that cannot be easily predicted. Here the authors setup a microfluidic platform that allows testing of multiple drug combinations correctly predicting sensitivity in vivo and they use it on patients biopsies to define effective...
Enregistré dans:
Auteurs principaux: | Federica Eduati, Ramesh Utharala, Dharanija Madhavan, Ulf Peter Neumann, Thomas Longerich, Thorsten Cramer, Julio Saez-Rodriguez, Christoph A. Merten |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b6bc84e761d240379ee00dadd6ae25c4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Droplet-based microfluidic platform for high-throughput screening of Streptomyces
par: Ran Tu, et autres
Publié: (2021) -
Tumour-on-chip microfluidic platform for assessment of drug pharmacokinetics and treatment response
par: Tudor Petreus, et autres
Publié: (2021) -
Precision cell-free DNA extraction for liquid biopsy by integrated microfluidics
par: Hoyoon Lee, et autres
Publié: (2020) -
Efficient molecular evolution to generate enantioselective enzymes using a dual-channel microfluidic droplet screening platform
par: Fuqiang Ma, et autres
Publié: (2018) -
CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response
par: Karol Szlachta, et autres
Publié: (2018)